Search results
Gilead's long-acting HIV drug superior to daily pill Truvada in study
Reuters via AOL· 3 days ago(Reuters) -Gilead Sciences said on Thursday a late-stage study showed its long-acting injectable...
Federal appeals court says some employers can exclude HIV prep from insurance coverage
Associated Press· 2 days agoEmployers who challenged some federal health insurance requirements cannot be forced to provide...
FDOH hosting several HIV testing events in Orange County
WKMG ClickOrlando· 2 days agoOn Saturday, FDOH will be offering free HIV testing at two locations. One of them is at the Mexican...
Gilead's twice-a-year HIV PrEP drug delivers stunning results in late-stage study - San Francisco...
The Business Journals· 3 days agoInjected only twice a year, an HIV PrEP drug developed by Gilead Sciences Inc. showed zero...
Gilead Flashes Bullish Sign After HIV Drug Proves 100% Effective
Investor's Business Daily· 3 days agoThe news is a boon for Gilead Sciences (GILD), which already sells its HIV drugs Descovy and Truvada...
Federal appeals court says some employers can exclude HIV prep from insurance coverage
NBC Dallas Fort Worth· 2 days agoEmployers who challenged some federal health insurance requirements cannot be forced to provide...
Fort Worth HIV survivors defy disease that once ensured death by growing old together
CBS News· 5 days agoHIV and AIDS used to be a death sentence for many in the 80s and 90s. One group of survivors gathers...
Gilead’s HIV prevention treatment found 100% effective in late-stage trial
Market Watch· 3 days agoGilead Sciences Inc.’s stock jumped early Thursday after the company said its experimental injection...
Dignity Health Management Center offering free HIV testing June 27th
KTAB Abilene via Yahoo News· 1 day agoThursday, June 27th is National HIV Testing Day and The Dignity Health Management Center in Abilene...
Gilead Flashes A Bullish Sign After HIV Drug Proves 100% Effective
Investor's Business Daily· 3 days agoGilead stock surged Thursday, retaking its 50-day line, after its twice-annual shot proved 100%...